Adia Nutrition ADIA
OTC ADIA
$0.12 +0.00 (+0.00%)
At close: Sep 17, 2026 · 4:00 PM EDT

Adia Nutrition (ADIA) Total Non-Current Liabilities (2024 - 2026)

Adia Nutrition's (ADIA) quarterly Total Non-Current Liabilities came in at $87395.0 in Q1 2026, down 18.55% quarter-over-quarter from $107305.0 in Q4 2025.

Analysis

Adia Nutrition (ADIA) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

Adia Nutrition (ADIA) has reported Total Non-Current Liabilities for 3 consecutive years, with $87395.0 the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $87395.0 in Q1 2026; TTM through Mar 2026 was $87395.0, a N/A change from a year earlier, with the FY2025 full-year figure at $107305.0, down 80.86% from the prior year.
  • Total Non-Current Liabilities was $87395.0 for Q1 2026 at Adia Nutrition, down from $107305.0 in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $560648.0 in Q4 2024 and troughed at $87395.0 in Q1 2026.
  • A 3-year average of $251782.7 and a median of $107305.0 in 2025 frame the typical range for Total Non-Current Liabilities.
  • The widest YoY moves for Total Non-Current Liabilities: up 80.86% in 2025, down 80.86% in 2025.
  • Over 3 years, Total Non-Current Liabilities stood at $560648.0 in 2024, then slumped by 80.86% to $107305.0 in 2025, then decreased by 18.55% to $87395.0 in 2026.
  • The last three Total Non-Current Liabilities figures came in at $87395.0 (Q1 2026), $107305.0 (Q4 2025), and $560648.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Krystal Biotech 9.96 Bn 9.12 Bn 112.79 Mn 134.44 Mn
2 CRISPR Therapeutics AG 5.47 Bn 5.47 Bn - 898.00 Mn
3 Iovance Biotherapeutics 4.64 Bn 4.35 Bn 55.72 Mn 72.64 Mn
4 Legend Biotech 3.25 Bn 2.28 Bn 251.50 Mn 117.70 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 577.71 Mn
6 Precigen 2.79 Bn 2.79 Bn 52.17 Mn 126.64 Mn
7 Beam Therapeutics 2.58 Bn 2.58 Bn - 313.33 Mn
8 Sarepta Therapeutics 2.12 Bn 1.33 Bn 251.87 Mn 1.66 Bn
9 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 130.91 Mn
10 Adia Nutrition 11.33 Mn 11.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 87,395.00
Dec 31, 2025 107,305.00
Dec 31, 2024 560,648.00